ENTITY
Serplulimab injection
Serplulimab injection
PulseAugur coverage of Serplulimab injection — every cluster mentioning Serplulimab injection across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TIMELINE
- 2026-05-10 product_launch European Commission approved two new indications for Serplulimab Injection (Hetronifly®). source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Titan Co. stock surges amid R&D clarification; Fosun Pharma drug gains EU approval
Titan Co. announced its stock price experienced abnormal fluctuations, with a cumulative increase exceeding 20% over three trading days. The company clarified that its high-end electronic fabric jet looms are still in t…
-
Fosun Pharma subsidiary gains EU approval for two new cancer drug indications
Fosun Pharma announced that its subsidiary, Shanghai Henlius Biotech, has received European Commission approval for two new indications for its drug, Serplulimab Injection (Hetronifly®). These approvals cover the first-…